Biomarkers of kidney disease

Clinical applications for biomarkers include monitoring illness activity, diagnosing it, managing molecularly targeted therapies, and monitoring therapy response. Glomerular filtration rate (GFR) continues to be the ideal indicator of renal health. Kidney damage atoms and lipocalin associated with neutrophil gelatinase are thought to be useful biomarkers in plasma and urine to assess the severity and prognosis of Chronic Kidney Disease.

  • Decompensated heart failure

Related Conference of Biomarkers of kidney disease

August 28-29, 2025

10th World Kidney Congress

London, UK
November 03-04, 2025

29th European Nephrology Conference

Rome, Italy
December 10-11, 2025

12th World Congress on Epidemiology & Public Health

Amsterdam, Netherlands
March 09-10, 2026

17th Nephrology,Renal Medicine & Renal Care

Dubai, UAE
March 26-27, 2026

22nd World Nephrology Conference

Amsterdam, Netherlands
June 29-30, 2026

18th World Nephrology Summit

Aix-en-Provence, France

Biomarkers of kidney disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in